Searched for: in-biosketch:yes
person:samanm01
Sequencing identifies multiple early introductions of SARS-CoV-2 to the New York City Region
Maurano, Matthew T; Ramaswami, Sitharam; Zappile, Paul; Dimartino, Dacia; Boytard, Ludovic; Ribeiro-Dos-Santos, André M; Vulpescu, Nicholas A; Westby, Gael; Shen, Guomiao; Feng, Xiaojun; Hogan, Megan S; Ragonnet-Cronin, Manon; Geidelberg, Lily; Marier, Christian; Meyn, Peter; Zhang, Yutong; Cadley, John A; Ordoñez, Raquel; Luther, Raven; Huang, Emily; Guzman, Emily; Arguelles-Grande, Carolina; Argyropoulos, Kimon V; Black, Margaret; Serrano, Antonio; Call, Melissa E; Kim, Min Jae; Belovarac, Brendan; Gindin, Tatyana; Lytle, Andrew; Pinnell, Jared; Vougiouklakis, Theodore; Chen, John; Lin, Lawrence H; Rapkiewicz, Amy; Raabe, Vanessa; Samanovic, Marie I; Jour, George; Osman, Iman; Aguero-Rosenfeld, Maria; Mulligan, Mark J; Volz, Erik M; Cotzia, Paolo; Snuderl, Matija; Heguy, Adriana
Effective public response to a pandemic relies upon accurate measurement of the extent and dynamics of an outbreak. Viral genome sequencing has emerged as a powerful approach to link seemingly unrelated cases, and large-scale sequencing surveillance can inform on critical epi-demiological parameters. Here, we report the analysis of 864 SARS-CoV-2 sequences from cases in the New York City metropolitan area during the COVID-19 outbreak in Spring 2020. The majority of cases had no recent travel history or known exposure, and genetically linked cases were spread throughout the region. Comparison to global viral sequences showed that early transmission was most linked to cases from Europe. Our data are consistent with numerous seeds from multiple sources and a prolonged period of unrecognized community spreading. This work highlights the complementary role of genomic surveillance in addition to traditional epidemiological indicators.
PMID: 33093069
ISSN: 1549-5469
CID: 4642522
LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection [PrePrint]
Jones, Bryan E; Brown-Augsburger, Patricia L; Corbett, Kizzmekia S; Westendorf, Kathryn; Davies, Julian; Cujec, Thomas P; Wiethoff, Christopher M; Blackbourne, Jamie L; Heinz, Beverly A; Foster, Denisa; Higgs, Richard E; Balasubramaniam, Deepa; Wang, Lingshu; Bidshahri, Roza; Kraft, Lucas; Hwang, Yuri; Žentelis, Stefanie; Jepson, Kevin R; Goya, Rodrigo; Smith, Maia A; Collins, David W; Hinshaw, Samuel J; Tycho, Sean A; Pellacani, Davide; Xiang, Ping; Muthuraman, Krithika; Sobhanifar, Solmaz; Piper, Marissa H; Triana, Franz J; Hendle, Jorg; Pustilnik, Anna; Adams, Andrew C; Berens, Shawn J; Baric, Ralph S; Martinez, David R; Cross, Robert W; Geisbert, Thomas W; Borisevich, Viktoriya; Abiona, Olubukola; Belli, Hayley M; de Vries, Maren; Mohamed, Adil; Dittmann, Meike; Samanovic, Marie; Mulligan, Mark J; Goldsmith, Jory A; Hsieh, Ching-Lin; Johnson, Nicole V; Wrapp, Daniel; McLellan, Jason S; Barnhart, Bryan C; Graham, Barney S; Mascola, John R; Hansen, Carl L; Falconer, Ester
SARS-CoV-2 poses a public health threat for which therapeutic agents are urgently needed. Herein, we report that high-throughput microfluidic screening of antigen-specific B-cells led to the identification of LY-CoV555, a potent anti-spike neutralizing antibody from a convalescent COVID-19 patient. Biochemical, structural, and functional characterization revealed high-affinity binding to the receptor-binding domain, ACE2 binding inhibition, and potent neutralizing activity. In a rhesus macaque challenge model, prophylaxis doses as low as 2.5 mg/kg reduced viral replication in the upper and lower respiratory tract. These data demonstrate that high-throughput screening can lead to the identification of a potent antiviral antibody that protects against SARS-CoV-2 infection.
PMCID:7536866
PMID: 33024963
ISSN: 2692-8205
CID: 4626872
Sequencing identifies multiple, early introductions of SARS-CoV2 to New York City Region
Maurano, Matthew T; Ramaswami, Sitharam; Westby, Gael; Zappile, Paul; Dimartino, Dacia; Shen, Guomiao; Feng, Xiaojun; Ribeiro-Dos-Santos, Andre M; Vulpescu, Nicholas A; Black, Margaret; Hogan, Megan; Marier, Christian; Meyn, Peter; Zhang, Yutong; Cadley, John; Ordonez, Raquel; Luther, Raven; Huang, Emily; Guzman, Emily; Serrano, Antonio; Belovarac, Brendan; Gindin, Tatyana; Lytle, Andrew; Pinnell, Jared; Vougiouklakis, Theodore; Boytard, Ludovic; Chen, John; Lin, Lawrence H; Rapkiewicz, Amy; Raabe, Vanessa; Samanovic-Golden, Marie I; Jour, George; Osman, Iman; Aguero-Rosenfeld, Maria; Mulligan, Mark J; Cotzia, Paolo; Snuderl, Matija; Heguy, Adriana
Effective public response to a pandemic relies upon accurate measurement of the extent and dynamics of an outbreak. Viral genome sequencing has emerged as a powerful approach to link seemingly unrelated cases, and large-scale sequencing surveillance can inform on critical epidemiological parameters. Here, we report the analysis of 236 SARS-CoV2 sequences from cases in the New York City metropolitan area during the initial stages of the 2020 COVID-19 outbreak. The majority of cases throughout the region had no recent travel history or known exposure, and genetically linked cases were spread throughout the region. Comparison to global viral sequences showed that the majority were most related to cases from Europe. Our data are consistent with numerous seed transmissions from multiple sources and a prolonged period of unrecognized community spreading. This work highlights the complementary role of real-time genomic surveillance in addition to traditional epidemiological indicators.
PMCID:7276014
PMID: 32511587
ISSN: n/a
CID: 4477902
High titers of multiple antibody isotypes against the SARS-CoV-2 spike receptor-binding domain and nucleoprotein associate with better neutralization [PrePrint]
Noval, Maria G; Kaczmarek, Maria E; Koide, Akiko; Rodriguez-Rodriguez, Bruno A; Louie, Ping; Tada, Takuya; Hattori, Takamitsu; Panchenko, Tatyana; Romero, Larizbeth A; Teng, Kai Wen; Bazley, Andrew; de Vries, Maren; Samanovic, Marie I; Weiser, Jeffrey N; Aifantis, Ioannis; Cangiarella, Joan; Mulligan, Mark J; Desvignes, Ludovic; Dittmann, Meike; Landau, Nathaniel R; Aguero-Rosenfeld, Maria; Koide, Shohei; Stapleford, Kenneth A
ORIGINAL:0014801
ISSN: 2692-8205
CID: 4636922
Sequencing identifies multiple early introductions of SARS-CoV-2 to the New York City region
Maurano, Matthew T.; Ramaswami, Sitharam; Zappile, Paul; Dimartino, Dacia; Boytard, Ludovic; Ribeiro-dos-Santos, Andre M.; Vulpescu, Nicholas A.; Westby, Gael; Shen, Guomiao; Feng, Xiaojun; Hogan, Megan S.; Ragonnet-Cronin, Manon; Geidelberg, Lily; Marier, Christian; Meyn, Peter; Zhang, Yutong; Cadley, John; Ordonez, Raquel; Luther, Raven; Huang, Emily; Guzman, Emily; Arguelles-Grande, Carolina; Argyropoulos, Kimon V.; Black, Margaret; Serrano, Antonio; Call, Melissa E.; Kim, Min Jae; Belovarac, Brendan; Gindin, Tatyana; Lytle, Andrew; Pinnell, Jared; Vougiouklakis, Theodore; Chen, John; Lin, Lawrence H.; Rapkiewicz, Amy; Raabe, Vanessa; Samanovic, Marie I.; Jour, George; Osman, Iman; Aguero-Rosenfeld, Maria; Mulligan, Mark J.; Volz, Erik M.; Cotzia, Paolo; Snuderl, Matija; Heguy, Adriana
ISI:000596075800008
ISSN: 1088-9051
CID: 5525422
Mycobacterium tuberculosis Rv2700 Contributes to Cell Envelope Integrity and Virulence
Ballister, Edward R; Samanovic, Marie I; Darwin, K Heran
The cell envelope of Mycobacterium tuberculosis (M. tuberculosis) is a key target for antibiotics, yet its assembly and maintenance remain incompletely understood. Here we report that Rv2700, a previously uncharacterized M. tuberculosis gene, contributes to envelope integrity. Specifically, an Rv2700 mutant strain had decreased growth rate, increased sensitivity to antibiotics that target peptidoglycan crosslinking, and increased cell envelope permeability. We propose that Rv2700 be named "cell envelope integrity" (cei). Importantly, a cei mutant had attenuated virulence in mice. Cei shares predicted structural homology with another M. tuberculosis protein, VirR (Rv0431), and we found that a virR mutant demonstrated similar growth rate, antibiotic sensitivity and envelope permeability phenotypes as the cei mutant. Both Cei and VirR are predicted to consist of a transmembrane helix and an extracellular LytR_C domain. LytR_C domains have no known function, but they are also found in a family of proteins, the LCP enzymes, that perform important cell envelope functions in a range of bacteria. In mycobacteria, LCP enzymes attach arabinogalactan to peptidoglycan, and mycobacterial LCP enzyme mutants demonstrate similar phenotypes to virR- and cei-deficient strains. Collectively, our results suggest that LytR_C-domain proteins may contribute to the cell envelope functions performed by LCP proteins. This study provides a framework for further mechanistic investigations of LytR_C proteins, and, more broadly for advancing our understanding of the cell envelope of mycobacteria and other medically and economically important genera.ImportanceMycobacterium tuberculosis causes about 1.5 million deaths a year. The unique composition of the Mycobacterium tuberculosis cell envelope is required for this bacterium to cause disease, and is the target for several critical antibiotics. By better understanding the mechanisms by which mycobacteria assemble and maintain their cell envelope, we might uncover new therapeutic targets. In this work, we show that a previously uncharacterized protein, Rv2700, is important for cell envelope integrity in Mycobacterium tuberculosis, and that loss of Rv2700 attenuates virulence in mice. This family of proteins is found in a broad group of bacterial species, so our work provides a first insight into their potential functions in many species important to the environment, industry, and human health.
PMID: 31285241
ISSN: 1098-5530
CID: 3976432
Cytokinin Signaling in Mycobacterium tuberculosis
Samanovic, Marie I; Hsu, Hao-Chi; Jones, Marcus B; Jones, Victoria; McNeil, Michael R; Becker, Samuel H; Jordan, Ashley T; Strnad, Miroslav; Xu, Changcheng; Jackson, Mary; Li, Huilin; Darwin, K Heran
It was recently reported that the human-exclusive pathogen Mycobacterium tuberculosis secretes cytokinins, which had only been known as plant hormones. While cytokinins are well-established, adenine-based signaling molecules in plants, they have never been shown to participate in signal transduction in other kingdoms of life. M. tuberculosis is not known to interact with plants. Therefore, we tested the hypothesis that cytokinins trigger transcriptional changes within this bacterial species. Here, we show cytokinins induced the strong expression of the M. tuberculosis gene Rv0077c. We found that Rv0077c expression is repressed by a TetR-like transcriptional repressor, Rv0078. Strikingly, cytokinin-induced expression of Rv0077c resulted in a loss of acid-fast staining of M. tuberculosis While acid-fast staining is thought to be associated with changes in the bacterial cell envelope and virulence, Rv0077c-induced loss of acid-fastness did not affect antibiotic susceptibility or attenuate bacterial growth in mice, consistent with an unaltered mycolic acid profile of Rv0077c-expressing cells. Collectively, these findings show cytokinins signal transcriptional changes that can affect M. tuberculosis acid-fastness and that cytokinin signaling is no longer limited to the kingdom Plantae.IMPORTANCE Cytokinins have only previously been known as plant hormones. The discovery that they can be used as signaling molecules outside of plants broadens the repertoire of small molecules that can potentially affect gene expression in all domains of life.
PMCID:6016246
PMID: 29921668
ISSN: 2150-7511
CID: 3157632
Loss-of-function mutations in HspR rescue the growth defect of a Mycobacterium tuberculosis proteasome activator E (pafE) mutant
Jastrab, Jordan B; Samanovic, Marie I; Copin, Richard; Shopsin, Bo; Darwin, K Heran
Mycobacterium tuberculosis uses a proteasome to degrade proteins by both ATP-dependent and -independent pathways. While much has been learned about ATP-dependent degradation, relatively little is understood about the ATP-independent pathway, which is controlled by Mycobacterium tuberculosis proteasome accessory factor E (PafE). Recently, we found that a Mycobacterium tuberculosis pafE mutant has slowed growth in vitro and is sensitive to killing by heat stress. However, we did not know if these phenotypes were caused by an inability to degrade the PafE-proteasome substrate HspR (heat shock protein repressor), an inability to degrade any damaged or misfolded proteins, or a defect in another protein quality control pathway. To address this question, we characterized pafE suppressor mutants that grew similarly to pafE+ bacteria under normal culture conditions. All but one suppressor mutant analyzed contained mutations that inactivated HspR function, demonstrating that the slowed growth and heat shock sensitivity of a pafE mutant was caused specifically by the inability of the proteasome to degrade HspR. IMPORTANCE: Mycobacterium tuberculosis (Mtb) encodes a proteasome that is highly similar to eukaryotic proteasomes and is required for virulence. We recently discovered a proteasome cofactor, PafE, which is required for the normal growth, heat shock resistance, and full virulence of Mtb In this study, we demonstrate that PafE influences this phenotype primarily by promoting the expression of protein chaperone genes that are necessary for surviving proteotoxic stress.
PMCID:5350283
PMID: 28096448
ISSN: 1098-5530
CID: 2413862
Game of 'Somes: Protein Destruction for Mycobacterium tuberculosis Pathogenesis
Samanovic, Marie I; Darwin, K Heran
The proteasome system of Mycobacterium tuberculosis is required for causing disease. Proteasomes are multisubunit chambered proteases and, until recently, were only known to participate in adenosine triphosphate (ATP)-dependent proteolysis in bacteria. In this review, we discuss the latest advances in understanding how both ATP-dependent and ATP-independent proteasome-regulated pathways contribute to M. tuberculosis virulence.
PMCID:4698092
PMID: 26526503
ISSN: 1878-4380
CID: 1825802
Cytokinins beyond plants: synthesis by Mycobacterium tuberculosis [Comment]
Samanovic, Marie I; Darwin, K H
Mycobacterium tuberculosis (M. tuberculosis) resides mainly inside macrophages, which produce nitric oxide (NO) to combat microbial infections. Earlier studies revealed that proteasome-associated genes are required for M. tuberculosis to resist NO via a previously uncharacterized mechanism. Twelve years later, we elucidated the link between proteasome function and NO resistance in M. tuberculosis in Molecular Cell, 57 (2015), pp. 984-994. In a proteasome degradation-defective mutant, Rv1205, a homologue of the plant enzyme LONELY GUY (LOG) that is involved in the synthesis of phytohormones called cytokinins, accumulates and as a consequence results in the overproduction of cytokinins. Cytokinins break down into aldehydes that kill mycobacteria in the presence of NO. Importantly, this new discovery reveals for the first time that a mammalian bacterial pathogen produces cytokinins and leaves us with the question: why is M. tuberculosis, an exclusively human pathogen, producing cytokinins?
PMCID:5349239
PMID: 28357289
ISSN: 2311-2638
CID: 2508402